Reviva Pharmaceuticals Holdings, Inc.
NASDAQ:RVPH
1.58 (USD) • At close January 14, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Reviva Pharmaceuticals Holdings, Inc. |
Symbool | RVPH |
Munteenheid | USD |
Prijs | 1.58 |
Beurswaarde | 73,595,136 |
Dividendpercentage | 0% |
52-weken bereik | 0.6 - 4.83 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Dr. Laxminarayan Bhat Ph.D. |
Website | https://revivapharma.com |
An error occurred while fetching data.
Over Reviva Pharmaceuticals Holdings, Inc.
Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP5063, which is in Phase III clinical trials for the treatment
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)